Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elgene Lim

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Nature Cancer|February 28, 2022
A new sophistication for breast cancer PDXsNeil Portman, Elgene Lim
Oncology (Williston Park, N.Y.)|August 22, 2014
Updates on the management of breast cancer brain metastasesElgene Lim, Nancy U Lin
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant chemotherapy in luminal breast cancersElgene Lim, Eric P Winer
Oncology (Williston Park, N.Y.)|August 15, 2012
New insights and emerging therapies for breast cancer brain metastasesElgene Lim, Nancy U Lin
Cancers|October 13, 2021
Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the ClinicSanjeev Kumar, Allegra Freelander, Elgene Lim
Frontiers in Oncology|November 22, 2021
MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast CancerNeil Portman, Julia Chen, Elgene Lim
Asia-Pacific Journal of Clinical Oncology|September 7, 2021
The management of HER2-positive early breast cancer: Current and future therapiesJulia Chen, Maree Colosimo, Elgene Lim
Proteomics|July 18, 2017
Secreted Tumor Antigens - Immune Biomarkers for Diagnosis and TherapyEls Meeusen, Elgene Lim, Suresh Mathivanan
Clinical Endocrinology|August 7, 2016
Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed?Sabashini K Ramchand, Elgene Lim, Mathis Grossmann
British Journal of Cancer|September 23, 2016
Renewed interest in the progesterone receptor in breast cancerElgene Lim, Carlo Palmieri, Wayne D Tilley
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Nature Cancer|February 28, 2022
A new sophistication for breast cancer PDXsNeil Portman, Elgene Lim
Oncology (Williston Park, N.Y.)|August 22, 2014
Updates on the management of breast cancer brain metastasesElgene Lim, Nancy U Lin
Breast (Edinburgh, Scotland)|October 22, 2011
Adjuvant chemotherapy in luminal breast cancersElgene Lim, Eric P Winer
Oncology (Williston Park, N.Y.)|August 15, 2012
New insights and emerging therapies for breast cancer brain metastasesElgene Lim, Nancy U Lin
Cancers|October 13, 2021
Type 1 Nuclear Receptor Activity in Breast Cancer: Translating Preclinical Insights to the ClinicSanjeev Kumar, Allegra Freelander, Elgene Lim
Frontiers in Oncology|November 22, 2021
MDM2 as a Rational Target for Intervention in CDK4/6 Inhibitor Resistant, Hormone Receptor Positive Breast CancerNeil Portman, Julia Chen, Elgene Lim
Asia-Pacific Journal of Clinical Oncology|September 7, 2021
The management of HER2-positive early breast cancer: Current and future therapiesJulia Chen, Maree Colosimo, Elgene Lim
Proteomics|July 18, 2017
Secreted Tumor Antigens - Immune Biomarkers for Diagnosis and TherapyEls Meeusen, Elgene Lim, Suresh Mathivanan
Clinical Endocrinology|August 7, 2016
Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed?Sabashini K Ramchand, Elgene Lim, Mathis Grossmann
British Journal of Cancer|September 23, 2016
Renewed interest in the progesterone receptor in breast cancerElgene Lim, Carlo Palmieri, Wayne D Tilley
Pageof 13